Developmental and Full-Life Cycle Exposures to Guanylurea and Guanylurea–Metformin Mixtures Results in Adverse Effects on Japanese Medaka (Oryzias latipes)
- 5 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 38 (5) , 1023-1028
Abstract
Metformin is currently thought to be the highest drug by weight released into the aquatic environment, as a direct result of its widespread use in the treatment of a number of human health disorders. The removal of metformin from wastewaters is directly related to the formation of guanylurea (metformin's only known persistent degradation product), which is generally present at higher concentrations in surface waters than the parent compound. With metformin use rising steadily, it is important to characterize the effects of guanylurea on nontarget aquatic organisms. We recently demonstrated the effects of developmental exposure to environmentally relevant concentrations of metformin on the growth of early life stage (ELS) medaka as well as effects on the body weight of adult male fish following full-life cycle exposures. In the present study, we describe similar effects of guanylurea exposure on these endpoints and life stages. Guanylurea led to effects on growth in a 28-d ELS assessment that were similar to those of metformin; however, these effects occurred at concentrations in the ng/L range compared with the μg/L range for metformin. A possible sex-dependent association with body weight changes was also observed in adults following a 165-d full-life cycle exposure to guanylurea alone or in a mixture with metformin. To our knowledge, the present is the first study to report the toxicity of guanylurea to nontarget aquatic organisms. Environ Toxicol Chem 2019;00:1–6. © 2019 SETACKeywords
Funding Information
- Canada Research Chairs (950-221924)
- Natural Sciences and Engineering Research Council of Canada (360557-2011)
- Canada Research Chairs (950‐221924)
- Natural Sciences and Engineering Research Council of Canada (360557‐2011)
This publication has 16 references indexed in Scilit:
- Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycleEnvironment International, 2014
- Occurrence of PCPs in Natural Waters from Europe2014
- Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewaterScience of The Total Environment, 2013
- Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales dataScience of The Total Environment, 2013
- Metformin pathwaysPharmacogenetics and Genomics, 2012
- Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatmentWater Research, 2012
- Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future researchAnalytical and Bioanalytical Chemistry, 2010
- Pharmaceuticals in the aquatic environment: A critical review of the evidence for health effects in fishCritical Reviews in Toxicology, 2010
- Stages of normal development in the medaka Oryzias latipesMechanisms of Development, 2004
- Pharmacokinetics of metformin after intravenous and oral administration to manEuropean Journal of Clinical Pharmacology, 1979